Cubist Systematic Strategies’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Cubist Systematic Strategies’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-120,907	Closed	-$9.07K	–	4598
2023 Q1	$9.07K	Hold	120,907	–	–	﹤0.01%	3729
2022 Q4	$617	Hold	120,907	–	–	﹤0.01%	4163
2022 Q3	$10K	Sell	120,907 -7,322	-6%	-$1.28K	﹤0.01%	4291
2022 Q2	$14K	Hold	128,229	–	–	﹤0.01%	4250
2022 Q1	$45K	Buy	+128,229	New	+$51.9K	﹤0.01%	3403

Cubist Systematic Strategies's LVACW Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 120,907 shares — an estimated $9.07K sold.

Cubist Systematic Strategies first reported a position in LVACW in Q1 2022 and held it in 5 quarters. The position peaked at $45K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Cubist Systematic Strategies reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 120,907 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $9.07K.
Cubist Systematic Strategies first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 5 quarters.
Cubist Systematic Strategies's LAVA Medtech Acquisition Corp. Warrants position peaked at $45K in Q1 2022.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.